Last viewed:
ABIO
Prices are updated after-hours
ABIO
|
$3.4
4.61%
4.41%
920K
|
Health Technology
(0.0% 1d)
(91.0% 1m)
(75.3% 1y)
(0.0% 2d)
(5.9% 3d)
(6.9% 7d)
(874.25%
volume)
Earnings Calendar:
Market Cap: $ 49,303,886
http://www.arcabiopharma.com
Sec
Filling
|
Patents
| 13 employees
(US) ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.
cardiovascular
heart
genetic
treatment
add to watch list
Paper trade
email alert is off
Press-releases
INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ChampionX Corp. - CHX
Published: 2024-04-10
(Crawled : 01:00)
- prnewswire.com
ABIO
|
$3.4
4.61%
4.41%
920K
|
Health Technology
| 10.39%
| O: 1.62%
H: 1.92%
C: 0.32%
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Kintara Biopharma, Inc. - KTRA
Published: 2024-04-10
(Crawled : 01:00)
- prnewswire.com
SWAV
|
$329.02
0.46%
0.46%
1.3M
|
Health Technology
| 0.5%
| O: -0.32%
H: 1.09%
C: 1.02%
KTRA
|
$0.1204
12.95%
11.46%
7.1M
|
Distribution Services
| -10.04%
| O: -2.17%
H: 0.15%
C: -1.69%
ABIO
|
$3.4
4.61%
4.41%
920K
|
Health Technology
| 10.39%
| O: 1.62%
H: 1.92%
C: 0.32%
Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm
Published: 2024-04-05
(Crawled : 18:00)
- prnewswire.com
SUN
3
d
|
$55.5
2.08%
0.7%
420K
|
Distribution Services
| -5.92%
| O: 0.0%
H: 0.14%
C: -1.49%
NS
3
d
|
$22.11
2.13%
0.0%
560K
|
Distribution Services
| -3.7%
| O: -0.44%
H: 0.96%
C: -0.09%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
| -4.81%
| O: -1.84%
H: 0.0%
C: 0.0%
SWAV
|
$329.02
0.46%
0.46%
1.3M
|
Health Technology
| 2.29%
| O: 1.21%
H: 0.65%
C: 0.25%
KTRA
|
$0.1204
12.95%
11.46%
7.1M
|
Distribution Services
| -16.49%
| O: -13.08%
H: 8.09%
C: 4.16%
ABIO
|
$3.4
4.61%
4.41%
920K
|
Health Technology
| 10.39%
| O: -3.9%
H: 7.09%
C: 4.39%
ARCA biopharma Announces 2023 Financial Results
Published: 2024-02-01
(Crawled : 22:00)
- globenewswire.com
ABIO
|
$3.4
4.61%
4.41%
920K
|
Health Technology
| 115.87%
| O: -0.32%
H: 5.1%
C: 3.18%
biopharma
financial
results
ARCA biopharma Announces Third Quarter 2023 Financial Results
Published: 2023-10-18
(Crawled : 20:00)
- globenewswire.com
ABIO
|
$3.4
4.61%
4.41%
920K
|
Health Technology
| 66.67%
| O: -0.88%
H: 0.89%
C: 0.39%
biopharma
financial
results
Global Aptamers Market Landscape 2023-2030: Diagnostics Segment Set for Rapid Expansion, North America Holds Key Position
Published: 2023-08-22
(Crawled : 18:00)
- prnewswire.com
ABIO
|
$3.4
4.61%
4.41%
920K
|
Health Technology
| 65.85%
| O: -0.49%
H: 1.47%
C: 0.98%
america
rapid
global
set
diagnostics
market
ARCA biopharma Announces Second Quarter 2023 Financial Results
Published: 2023-07-21
(Crawled : 20:00)
- globenewswire.com
ABIO
|
$3.4
4.61%
4.41%
920K
|
Health Technology
| Email alert
Add to watchlist
biopharma
financial
results
ARCA biopharma Announces First Quarter 2023 Financial Results
Published: 2023-04-24
(Crawled : 21:00)
- globenewswire.com
ABIO
|
$3.4
4.61%
4.41%
920K
|
Health Technology
| 73.47%
| O: 0.0%
H: 1.21%
C: 0.0%
biopharma
financial
results
ARCA biopharma Announces Third Quarter 2022 Financial Results
Published: 2022-10-28
(Crawled : 21:00)
- globenewswire.com
ABIO
|
$3.4
4.61%
4.41%
920K
|
Health Technology
| Email alert
Add to watchlist
biopharma
financial
results
ARCA biopharma Reports Topline Results for ASPEN-COVID-19 Phase 2b Clinical Trial
Published: 2022-03-31
(Crawled : 23:00)
- biospace.com/
ABIO
|
$3.4
4.61%
4.41%
920K
|
Health Technology
| 46.55%
| O: -1.72%
H: 7.89%
C: 0.88%
covid-19
biopharma
topline
trial
results
phase 2b
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount